In summary, MCM3AP-AS1 overexpression in CRC implies an increased risk of an unfavorable prognosis and intensifies the invasiveness and proliferation of CRC cells by activating the VEGF/VEGFR2 signaling pathway. The gene discussed is VEGFA; the disease is colorectal carcinoma.